Peptide therapy TikTok claims: what the science actually supports

What did @steffbelly8888 actually say?

She is not making a health claim here, she is asking for technique advice. Specifically, she says she has been injecting glutathione and L-carnitine subcutaneously but has been told they are "so much better intramuscularly." She wants to know needle gauge, pain-reduction tips, and whether the route difference is real or just hype. That is a legitimate question, and the fact that she is asking rather than just declaring something is actually refreshing on a platform where confident misinformation is the norm.

The anxiety she describes about self-injecting intramuscularly is also completely understandable. Intramuscular injections require different technique, a longer needle, and more anatomical awareness than subcutaneous shots. She is not being dramatic. The fear is rational.

Does the science back this up?

The claim that IM is automatically "so much better" than subcutaneous for these two compounds is an oversimplification, and the evidence is thinner than TikTok peptide communities tend to admit. For L-carnitine specifically, there is some support for the idea that intravenous delivery produces higher plasma concentrations faster than oral, but the IM versus subcutaneous comparison in humans is not well-studied in outpatient self-injection contexts.

For glutathione, the picture is even murkier. A 2017 randomized trial by Weschawalit et al. in Clinical, Cosmetic and Investigational Dermatology found that topical and oral glutathione produced measurable skin-lightening effects, but this was not an IM versus subcutaneous trial. The pharmacokinetic argument for IM glutathione in particular relies heavily on absorption rate differences, and those differences, while real in principle, have not been robustly quantified in peer-reviewed human trials for this specific compound and route combination. The "so much better" framing someone told her is anecdote dressed up as pharmacology.

What did they get wrong (or right)?

She did not actually claim anything false. She is repeating advice she received and questioning it, which is the right posture. Credit where it is due.

What she got partially wrong, or rather what the advice she received got wrong, is the blanket assertion that IM is universally superior. Route of administration matters, but the magnitude of the difference depends heavily on the specific compound, formulation, concentration, and clinical goal. L-carnitine injected IM does show faster peak plasma levels compared to oral supplementation (Brass, 2000, Molecular Genetics and Metabolism), but the IM versus subcutaneous delta for self-administered doses is not the same as IV versus oral in a clinical trial. These are different comparisons, and conflating them is how misinformation spreads in wellness communities.

The needle gauge question is practical and reasonable. Standard IM injection needles range from 22 to 25 gauge, 1 to 1.5 inches, depending on injection site and body composition. That is not a medical recommendation, that is publicly available clinical nursing literature (Perry, Potter and Ostendorf, Clinical Nursing Skills, 2018).

What should you actually know?

If you are self-injecting any compound, route of administration is a real pharmacokinetic variable, but it is not the only one. Bioavailability differences between subcutaneous and IM delivery for peptides and amino acid derivatives are compound-specific. Some peptides, like BPC-157, have been studied in both routes in animal models with comparable efficacy signals, though human clinical trial data remains limited across the board.

More practically: self-administered IM injections carry higher risk than subcutaneous ones. The deltoid, vastus lateralis, and ventrogluteal sites each have specific landmarks to avoid nerve and vessel damage. Getting this wrong is not a minor inconvenience. Sciatic nerve injury from improper dorsogluteal injection is a documented clinical complication (Small, 2004, Journal of Advanced Nursing).

Anyone considering switching routes should do so under the guidance of a licensed clinician, not a TikTok comment section, regardless of how experienced those commenters claim to be. The question she is asking is valid. The forum she is asking it in is the problem.

Bottom line

This video is more self-aware than most in the peptide space. She is not selling anything, not claiming miraculous results, and not pretending to be an expert. The core premise she was handed, that IM is always meaningfully better than subcutaneous for these compounds, is not well-supported by clinical literature for the specific use case of self-injection in healthy adults. The honest answer is: it depends, and the safety tradeoffs of switching routes deserve more attention than the absorption debate.